Thu. Jul 7th, 2022
Tatva Chintan IPO fully subscribed within first hour of bidding on Day 1 Tatva Chintan Pharma Chem IPO gets a subscribe rating from Anand Rathi, which is positive on the company#39;s long-term prospects